EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) (NCT06631638) | Clinical Trial Compass
RecruitingNot Applicable
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
United States118 participantsStarted 2025-10-24
Plain-language summary
The purpose of this research is to gather clinical and radiographic (X-ray) information about EMPHASYS™ acetabular shell (also called a hip 'cup') placement in total hip replacement surgery using a non-invasive surgical navigation system called VELYS™ hip navigation system with CUPTIMIZE™ Advanced Hip-Spine Analysis software.
Data collected in this study will be compared with data collected from implantations using different cup positioning instrumentation and techniques to assess performance.
Who can participate
Age range21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
âś“. All hip replacement component devices are to be used according to the approved indications.
âś“. The subject is undergoing a standard of care primary uncemented hip replacement with the EMPHASYS cup and a CORAIL, EMPHASYS or ACTIS stem via the posterolateral, anterolateral, or direct lateral approach with the subject in the lateral decubitus position.
âś“. The subject is a candidate for implantation utilizing the VELYS Hip Navigation system with CUPTIMIZE advanced
âś“. Individuals who are able to speak, read, and comprehend the Informed Participant Consent Document and willing and able to provide consent for participation in the study and have authorized the transfer of his/her information to DePuy Synthes.
âś“. Individuals who are willing and able to complete follow-up as specified by the study protocol.
âś“. Individuals who are willing and able to complete the Subject Hip Outcomes questionnaires (i.e., FJS-12, EQ-5D-5L and Hip Evaluation) as specified by the study protocol.
âś“. Individuals who are not bedridden per the discretion of the investigator.
âś“. Individuals who are a minimum age of 21 years at the time of consent
Exclusion criteria
âś•. Active local or systemic infection.
âś•. Loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified.
What they're measuring
1
Composite endpoint: Acetabular Cup Position Success at 6 Weeks
. Poor bone quality, such as osteoporosis, where, in the surgeon's opinion, there could be considerable migration of the prosthesis or a significant chance of fracture of the femoral shaft and/or the lack of adequate bone to support the implant(s).
âś•. Charcot's or Paget's disease.
âś•. The Subject is a woman who is pregnant or lactating.
âś•. Subject had a contralateral amputation.
âś•. Previous partial hip replacement in affected hip.
âś•. Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three months.